• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒渣鼻:诊断、分类和管理的最新进展。

Rosacea: An Update in Diagnosis, Classification and Management.

机构信息

Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Windsor Clinical Research, Windsor, ON, Canada.

出版信息

Skin Therapy Lett. 2021 Jul;26(4):1-8.

PMID:34347259
Abstract

The diagnosis and classification of rosacea has been modified to reflect presenting features. On exclusion of differentials, the diagnosis of rosacea is based on the presence of either (1) phymatous changes, or (2) centrofacial persistent erythema. In their absence, diagnosis can be established by presence of any two of: flushing/transient erythema, papules and pustules, telangiectases, or ocular manifestations. Management of rosacea depends on presenting feature(s), their severity, and impact. General management includes gentle skin care, sun protection, and trigger avoidance. Evidence-based treatment recommendations include topical brimonidine and oxymetazoline for persistent erythema; topical azelaic acid, ivermectin, metronidazole, minocycline and oral doxycycline, tetracycline and isotretinoin for papules and pustules; vascular lasers and light devices for telangiectases; and omega-3 fatty acids and cyclosporine ophthalmic emulsion for ocular rosacea. While surgical or laser therapy can be considered for clinically noninflamed phyma, there are no trials on their utility. Combination therapies include topical brimonidine with topical ivermectin, or topical metronidazole with oral doxycycline. Topical metronidazole, topical ivermectin, and topical azelaic acid are appropriate for maintenance therapy. In conclusion, the updated phenotype approach, based on presenting clinical features, is the foundation for current diagnosis, classification, and treatment of rosacea.

摘要

酒渣鼻的诊断和分类已经修改,以反映其表现特征。在排除其他鉴别诊断后,酒渣鼻的诊断基于以下两种情况之一:(1) 永久性鼻肿,或(2) 中心面部持续性红斑。如果不存在这些情况,则可以通过以下两种或两种以上的表现来确立诊断:潮红/短暂性红斑、丘疹脓疱、毛细血管扩张或眼部表现。酒渣鼻的治疗取决于表现特征、严重程度和影响。一般管理包括温和的皮肤护理、防晒和避免触发因素。基于证据的治疗建议包括:持续红斑用局部布美他尼和羟甲唑啉;丘疹脓疱用局部壬二酸、伊维菌素、甲硝唑、米诺环素和口服多西环素、四环素和异维 A 酸;毛细血管扩张用血管激光和光设备;眼部酒渣鼻用欧米伽-3 脂肪酸和环孢素眼用乳液。虽然可以考虑手术或激光治疗非炎症性的临床永久性鼻肿,但目前还没有关于其疗效的试验。联合治疗包括局部布美他尼联合局部伊维菌素,或局部甲硝唑联合口服多西环素。局部甲硝唑、局部伊维菌素和局部壬二酸适用于维持治疗。总之,基于当前表现临床特征的更新表型方法是酒渣鼻当前诊断、分类和治疗的基础。

相似文献

1
Rosacea: An Update in Diagnosis, Classification and Management.酒渣鼻:诊断、分类和管理的最新进展。
Skin Therapy Lett. 2021 Jul;26(4):1-8.
2
Interventions for rosacea.酒渣鼻的干预措施。
Cochrane Database Syst Rev. 2015 Apr 28;2015(4):CD003262. doi: 10.1002/14651858.CD003262.pub5.
3
Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments.基于表型方法的酒渣鼻干预措施:一项包括 GRADE 评估的更新系统评价。
Br J Dermatol. 2019 Jul;181(1):65-79. doi: 10.1111/bjd.17590. Epub 2019 Mar 10.
4
S2k guideline: Rosacea.S2k 指南:酒渣鼻。
J Dtsch Dermatol Ges. 2022 Aug;20(8):1147-1165. doi: 10.1111/ddg.14849. Epub 2022 Aug 5.
5
Rosacea: Common Questions and Answers.酒渣鼻:常见问题与解答。
Am Fam Physician. 2024 Jun;109(6):533-542.
6
Rosacea.酒渣鼻。
Br J Hosp Med (Lond). 2021 Feb 2;82(2):1-8. doi: 10.12968/hmed.2020.0417. Epub 2021 Feb 27.
7
Rosacea: Diagnosis and Treatment.酒渣鼻:诊断与治疗
Am Fam Physician. 2015 Aug 1;92(3):187-96.
8
Advances in pharmacotherapy for rosacea: what is the current state of the art?玫瑰痤疮治疗的药理学进展:目前的最新技术是什么?
Expert Opin Pharmacother. 2022 Nov;23(16):1845-1854. doi: 10.1080/14656566.2022.2142907. Epub 2022 Nov 5.
9
Rosacea management: A comprehensive review.酒渣鼻管理:全面综述。
J Cosmet Dermatol. 2022 May;21(5):1895-1904. doi: 10.1111/jocd.14816. Epub 2022 Feb 14.
10
Rosacea Management.酒渣鼻的管理
Skin Appendage Disord. 2016 Sep;2(1-2):26-34. doi: 10.1159/000446215. Epub 2016 May 18.

引用本文的文献

1
Comparison of the efficacy and safety of pulsed dye laser, narrow-band intense pulsed light, and broad-band intense pulsed light in the treatment of erythematotelangiectatic rosacea.脉冲染料激光、窄谱强脉冲光和宽谱强脉冲光治疗红斑毛细血管扩张型玫瑰痤疮的疗效及安全性比较
Am J Transl Res. 2025 Jul 15;17(7):5530-5543. doi: 10.62347/LMUT4952. eCollection 2025.
2
Serum Zonulin and Its Role in Rosacea Pathogenesis: A Comprehensive Estimation Study.血清连蛋白及其在酒渣鼻发病机制中的作用:一项综合评估研究。
Dermatol Pract Concept. 2025 Jul 31;15(3):5027. doi: 10.5826/dpc.1503a5027.
3
Off-Label Treatment in Inflammatory Skin Diseases-European Point of View.
炎症性皮肤病的非标签治疗——欧洲视角
J Clin Med. 2025 Mar 30;14(7):2376. doi: 10.3390/jcm14072376.
4
Clinical manifestation and management of severe blepharokeratoconjunctivitis combined with corneal perforation.重度睑角膜结膜炎合并角膜穿孔的临床表现与处理
Int J Ophthalmol. 2025 Feb 18;18(2):229-236. doi: 10.18240/ijo.2025.02.05. eCollection 2025.
5
Corticosteroid-sparing topical treatment with cyclosporin for juvenile keratoconjunctivitis.环孢素用于青少年角结膜炎的糖皮质激素节省型局部治疗
Sci Rep. 2025 Feb 8;15(1):4671. doi: 10.1038/s41598-025-85256-z.
6
Exploring the Impact of Systemic Inflammatory Regulators on Rosacea Risk: A Bidirectional Mendelian Randomization Analysis.探索全身炎症调节因子对酒渣鼻风险的影响:一项双向孟德尔随机化分析
Clin Cosmet Investig Dermatol. 2025 Jan 20;18:191-200. doi: 10.2147/CCID.S495773. eCollection 2025.
7
Ocular Rosacea: An Updated Review.眼部酒渣鼻:最新综述
Cornea. 2025 Apr 1;44(4):525-537. doi: 10.1097/ICO.0000000000003785. Epub 2025 Jan 14.
8
Eosinophilic Annular Erythema Responding to Doxycycline.对强力霉素有反应的嗜酸性环状红斑
Cureus. 2023 Oct 22;15(10):e47478. doi: 10.7759/cureus.47478. eCollection 2023 Oct.
9
Topical ivermectin ointment treatment of Demodex blepharitis: a 6-year retrospective study.局部使用伊维菌素软膏治疗蠕形螨性睑缘炎:一项 6 年回顾性研究。
Graefes Arch Clin Exp Ophthalmol. 2024 Apr;262(4):1281-1288. doi: 10.1007/s00417-023-06281-0. Epub 2023 Nov 1.
10
The role of macrophages in rosacea: implications for targeted therapies.巨噬细胞在酒渣鼻中的作用:对靶向治疗的启示。
Front Immunol. 2023 Aug 24;14:1211953. doi: 10.3389/fimmu.2023.1211953. eCollection 2023.